675
Views
65
CrossRef citations to date
0
Altmetric
Review

Management of herpes zoster (shingles) and postherpetic neuralgia

&
Pages 551-559 | Published online: 02 Mar 2005

Bibliography

  • JOHNSON RW, DWORKIN RH: Treatment of herpes zoster and postherpetic neuralgia. Br. Med. .1. (2003) 326:748–750.
  • HOPE-SIMPSON RE: The nature of herpes zoster: a long-term study and a new hypothesis. Proceedings of the Royal Socieh, of Medicine (1965) 58:2–20.
  • ••A seminal paper describing epidemiologyand relationship of varicella to HZ. Edgar Hope-Simpson died at the age of 95 in 2003.
  • RAGGOZINO MW, MELTON LJ, KURLAND LT: Population-based study of herpes zoster and its sequelae. Medicine (1982) 61:310–316.
  • BRISSON M, EDMUNDS WJ: Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. I Med. Virol (2003) 70\(Suppl. 1):531–537.
  • CHOO PW, GALIL K,DONAHUE, J G, WALKER AM, SPIEGELMAN D, PLATT R: Risk factors for postherpetic neuralgia. Arch Intern. Med. (1997) 157(11):1217–24.
  • HELGASON S, PETURSSON G, GUDMUNDSSON S, SIGURDSSON JA: Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up.Br. Med. J. (2000) 321:794–796.
  • OXMAN MN: Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology (1995) 45\(Supp1.8): S41–45.
  • ••Discussion of the possible place of adultvaccination to enhance immunity to VZV
  • WEKSLER ME: Immune senescence. Ann. Neurol (1994) 35(Suppl.):S35–S37.
  • BERGER R, FOREST G, JUST M: Decrease of the lymphoproliferative response to varicella-zoster antigen in the aged. Infection and Immunology(1981) 32:24–27.
  • BURKE BL, STEELE RW, BEARD OW, WOOD JS, CAIN TD, MARMER DJ: Immune responses to varicella zoster in the elderly. Arch. Intern. Med. (1982) 142:291–293.
  • BENNETT GJ: Hypotheses on the pathogenesis of herpes zoster-associated pain. Ann. Neurol (1994) 35(Suppl.):S38–S41.
  • HAANPAA MD, HAKKINEN V, NURMIKKO T: Motor involvement in acute herpes zoster. Muscle Nerve (1997) 20:1433–1438.
  • ••Authoritative work on motor deficiencyand HZ.
  • BARON R, HAENDLER G, SCHULTE H: Afferent large fibre polyneuropathy predicts the development of postherpetic neuralgia. Pain (1997) 73:231–238.
  • WHITTON T, HOWELL T,JOHNSON RW: Use of the Rydel-Seiffer graduated tuning fork in the assessment of vibration threshold in postherpetic neuralgia patients and healthy controls. Abstract 422.T, Pain in Europe Iv: 4th congress of EFIC -the European Federation of the International Association for the Study of Pain, Prague, September 2–6 (2003).
  • GILDEN DH, COHRS RJ,HAYVVARD AR, WELLISH M, MAHALINGAM R: Chronic varicella zoster vitus ganglionitis - a possible cause for postherpetic neuralgia. Neuro. Virol (2003) 9:404–407.
  • ••Discussion of possible persistence ofVZV as a cause of PHN
  • McKENDRICK MW, CARE CC, KUDESIA G, BATES CJ, OXLEY MK,ELEY A: Is VZV reactivation a common cause of unexplained unilateral pain ? Results of a prospective study of 57 patients. Infect. (1999) 39(3):209–212.
  • KALMAN CM, LASKIN OL: Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am. Med. (1986) 81:775–778.
  • TORRENS J, NATHWANID,MACDONALD T, DAVEY PG: Acute herpes zoster in Tayside: Demographic and treatment details in immunocompetent patients between 1989-1992.Infect. (1998) 36:209–214.
  • MARTIN JR, MITCHELL J,HENKEN DB: Neurotropic herpes viruses, neural mechanisms and arteritis. Brain Pathol (1990) 1:6–10.
  • GILLANDERS I, MACKAY J, CAMPBELL F, MACLENNAN WJ: Herpes zoster encephalitis in the elderly. Postgrad. Med. J. (1994) 70(830):940 (Letter).
  • DWORKIN RH, PORTENOY RK: Proposed classification of herpes zoster pain. Lancet (1994) 343:1648.
  • ARANI RB, SOONG SJ, VVEISS HL, WOOD MJ, FIDDIAN PA, GNANN JW, WHITLEY RJ et al.: Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat. Med. (2001) 20:2429–2439.
  • ••Evidence for the three phase modelof pain associated with HZ.
  • DESMOND RA, WEISS HL, ARANI RB et al: Clinical application for change-point analysis of herpes zoster pain. Pain Symptom Manage. (2002) 23:510–516.
  • OAKLANDER AL, BOWSHER D, GALER B, HAANPAA M, JENSEN MP: Herpes zoster itch: preliminary epidemiologic data. Pain (2003) 4(6):338–43.
  • ••
  • ••
  • JUNG BE JOHNSON RW,GRIFFIN DRJ, DWORKIN RH: Risk factors for postherpetic neuralgia in patients with herpes zoster. Accepted for publication in Neurology
  • ••An analysis of a large cohort of HZ patients.
  • DAVIES L, COSSINS L,BOWSHER D,DRUMMOND M: The cost of treatment for postherpetic neuralgia in the United Kingdom. Pharmacoeconomics (1994) 6:142–148.
  • SMITH KJ, ROBERTS M.S: Cost effectiveness of newer antiviral agents for herpes zoster: is the evidence spotty? .1. Infect. Dis. (1998) 178\(Supp1.1):S85–S90.
  • WOOD MJ, KAY R, DWORKIN RH, SOONG SJ, WHITLEY RJ: Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials.Clin. Infect. Dis. (1996) 22:341–347.
  • BEUTNER KR, FRIEDMAN DJ, FORSZPANIAK C, ANDERSEN PL, WOOD MJ: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob. Agents Chemother: (1995) 39:1546–1553.
  • WASSILEW SW, WUTZLER P, BRIVUDIN HERPES ZOSTER STUDY GROUP: Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Res. (2003) 59(1):57–60.
  • WOOD MJ, JOHNSON RW, MCKENDRICK MW, TAYLOR J, MANDAL BK, CROOKS JA: Randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl. J. Med. (1994) 330:896–900.
  • ••First evidence for lack of effectiveness oforal steroid in preventing PHN.
  • WHITLEY RJ, WEISS H, GNANN JW Jr et al.: Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann. Intern. Med. (1996) 125(5):376–383.
  • HIGA K, HORI K, HARASAWA I, HIRATA K, DAN K: High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: Comparison with effects of stellateganglion block. Reg. Anesth. Pahl Med. (1998) 23:25–29.
  • PASQUALUCCI A, PASQUALUCCI V, GALLA F et al.: Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methyl prednisolone. Acta Anaesthesia Scand. (2000) 44:910–918.
  • WU CL, MARSH A, DWORKIN RH: The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain (2000) 87:121–129.
  • BOWSHER DR: The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J. Pahl Symptom Manage. (1997) 13:327–331.
  • COLLINS SL, MOORE RA,MCQUAY HJ: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J. Pain Symptom Manage. (2000) 20(6):449–458.
  • DALLOCCHIO C, BUFFA C, MAZZARELLO P, CHIROLI S: Gabapentin versus amitriptyline in painful diabetic neuropathy: an open-label pilot study. .1. Pain Symptom Manage. (2000) 4:280–285.
  • GRAFF-RADFORD SB, SHAW LR, NALIBOFF BN: Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin. .1. Pain (2000) 16:188–192.
  • WATSON CP, EVANS RJ, REED K, MORSKY H, GOLDSMITH L,WARSH J: Amitriptyline versus placebo in postherpetic neuralgia. Neurology(1982) 32:671–673.
  • WATSON CP, CHIPMAN M, REED K, EVANS RJ, BIRKETT N: Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain (1992) 48:29–36.
  • WATSON CP, VERNICH L, CHIPMAN M, REED K: Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology (1998) 51:1116–1171.
  • KISHORE-KUMAR R, MAX MB, SCHAFER SC et al: Desipramine relieves postherpetic neuralgia. Clin. Pharmaca Ther: (1990) 47(3):305–312.
  • MCCUE RE: Using tricyclic antidepressants in the elderly. Clin. Geriatr. Med. (1992) 8(2):323–334.
  • ROWBOTHAM M, HARDEN N, STACEY B, BERNSTEIN P, MAGNUS-MILLER L: Gabapentin for the treatment of postherpetic neuralgia. J. Am. Med. Assoc. (1998) 280(21):1837–1842.
  • ••First clear evidence for effectiveness ofgabapentin in PHN.
  • RICE ASC, MATON S,POSTHERPETIC NEURALGIA STUDY GROUP: Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain (2001) 94:215–224.
  • GERSON GR, JONES RB,LUSCOMBE DK: Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia. Postgrad. Med. j (1977) 53\(Supp1.4):104–109.
  • DWORKIN RH, CORBIN AE, YOUNG JP Jr et al.: Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology (2003) 60:1274–1283.
  • DEVERS A, GALER BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study.Clin. J. Pain (2000) 16:205–208.
  • ROWBOTHAM MC, DAVIES PS, VERKEMPINCK C, GALER B: Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain (1996) 65:39–44.
  • WATSON CPN, EVANS RJ, WATT VR et al.: A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Ther: (1993) 15(3):510–526.
  • GOBEL H, STADLER T: Traitement des douleurs post-zosteriennes par le tramadol. Clin. Drug Invest. (1995) 10(4):208–21.
  • BOUREAU F, LEGALLICIER P, KABIR-AHMADI M: Tramadol in postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain (2003) 104:323–331.
  • RAJA SN, HAYTHORNTHWAITE JA, PAPPAGALLO M et al.: Opioids versus antidepressants in postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology (2002) 59:1015–1021.
  • ROWBOTHAM MC, TWILLING L, DAVIES PS REISNER L, TAYLOR K, MOHR D: Oral opioid therapy for chronic peripheral and central neuropathic pain. N. Engl. J. Med. (2003) 348(13):1223–1232.
  • ••
  • WATSON CPN, BABUL N: Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology (1998) 50:1837–1841.
  • ••Evidence for effectiveness of opioid inneuropathic pain.
  • EIDE PK, JORUM E, STUBHAUG S, BREMNES J, BREIVIK H: Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain (1958) 58:347–354.
  • NELSON KA, PARK KM,ROBINOVITZ E, TSIGOS C, MAX MB: High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology (1997) 48:1212–1218.
  • SANG CN, BOOHER S, GILRON I, PARADA S, MAX MB: Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia. Anesthesiology (2002) 96:1053–1061.
  • KOTANI N, KUSHIKATA T, HASHIMOTO H et al.: Intrathecal methylprednisolone for intractable postherpetic neuralgia. N.Engl. I Med. (2000) 23:1514–1519.
  • NELSON DA: Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch. Neurol (1988) 45:804–806.
  • NELSON DA, LANDAU WM: Intraspinalsteroids: history, efficacy, accidentality and controversy with review of United States Food and Drug Administration reports. Neuro/. Neurosurg. Psychiatry (2001) 70(4):433–443.
  • INTERNATIONAL HERPES MANAGEMENT FORUM WORKSHOP: Improving the management of varicella, herpes zoster and zoster-associated pain. Johnson RW, Patrick D (Eds), Parexel MMS ISBN 0 904052 745 (2001).
  • http://www.IHMEorgThe International Herpes Management Forum website.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.